Quick Answer
Pulmatrix, Inc. reported Research And Development Expense of $38.0 thousand for the year ending 2025.
- Pulmatrix, Inc. showed a decrease of -99.5% in Research And Development Expense from 2024 to 2025.
- This data is from Pulmatrix, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2014 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 14 years of available data (2014 to 2025), Pulmatrix, Inc.'s Research And Development Expense has declined by 97.3%.
- Historical annual values: Fiscal year 2025: $38.0 thousand | Fiscal year 2024: $7.17 million | Fiscal year 2023: $15.52 million | Fiscal year 2022: $18.24 million | Fiscal year 2021: $15.38 million | Fiscal year 2020: $15.61 million | Fiscal year 2019: $12.85 million | Fiscal year 2018: $12.97 million | Fiscal year 2017: $10.24 million | Fiscal year 2016: $10.15 million | Fiscal year 2015: $7.19 million | Fiscal year 2015: $2.18 million | Fiscal year 2014: $6.59 million | Fiscal year 2014: $1.38 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: